681 REDUCED ANDROGEN DEPENDENT AND INDEPENDENT GROWTH OF HUMAN PROSTATE CANCER XENOGRAFTS IN GROWTH HORMONE RELEASING HORMONE RECEPTOR MUTANT HOSTS
โ Scribed by Takahara, Kiyoshi; Tearle, Howard; Tombe, Tabitha; Gleave, Martin E.; Cox, Michael E.
- Book ID
- 123463774
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2010
- Tongue
- English
- Weight
- 46 KB
- Volume
- 183
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for
## Background: Hormones like bombesin (bn)/gastrin-releasing peptide (grp) and luteinizing hormone-releasing hormone (lh-rh) and growth factors such as epidermal growth factor (egf) might be involved in the relapse of prostate cancer under androgen ablation therapy. interference with receptors for